Labb Introduces Two New DOT Look-alike Rapid Drug Tests
Labb releases two new drug tests that take the Department of Transportation requirements to the next level by adding Fentanyl & LSD.
The unique potential of these tests is significantly amplified when used in conjunction with Labb Station's technology and the laboratory and MRO services. "When leveraged with our partners' expertise and our groundbreaking Labb Station technology, the results generated by the UA:10C and UA:16C tests are designed to generate substantially equivalent final results to traditional laboratory testing," shares James Ramsey, President of Labb. "This new testing model focuses on efficiency, reliability, and accuracy of the drug testing process for others to follow."
By introducing the UA:10C and UA:16C, Labb continues to underscore its commitment to delivering state-of-the-art digital solutions that streamline and enhance drug testing outcomes. These latest tests exemplify Labb's ongoing commitment to accuracy and convenience, solidifying its position as an industry leader. Ramsey emphasized, "These innovative tests not only align with Labb's mission, but also enhance the core DOT panel by including drugs such as Fentanyl, Tramadol, and LSD." Labb Station now offers the most comprehensive workplace drug test on the market".
About Labb.comLabb.com is an industry leader in the realm of drug testing technology. With a robust blend of cutting-edge technology and user-friendly interfaces, Labb.com offers an array of products and services designed to simplify and modernize the drug testing process, including the Labb Station software, eTracking, and Labb Passport technology.
James Ramsey
Labb
+1 877-868-9967
james@labb.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
